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Abstract
Background: Hypoxia is a ubiquitous feature of many lung diseases and elicits cell-specific responses. While the
effects of hypoxia on stem cells have been examined under in vitro conditions, the consequences of in vivo
oxygen deprivation have not been studied.
Methods: We investigated the effects of in vivo hypoxia on a recently characterized population of pluripotent stem
cells known as very small embryonic-like stem cells (VSELs) by whole-genome expression profiling and measuring
peripheral blood stem cell chemokine levels.
Results: We found that exposure to hypoxia in mice mobilized VSELs from the bone marrow to peripheral blood, and
induced a distinct genome-wide transcriptional signature. Applying a computationally-intensive methodology, we
identified a hypoxia-induced gene interaction network that was functionally enriched in a diverse array of programs
including organ-specific development, stress response, and wound repair. Topographic analysis of the network
highlighted a number of densely connected hubs that may represent key controllers of stem cell response during
hypoxia and, therefore, serve as putative targets for altering the pathophysiologic consequences of hypoxic burden.
Conclusions: A brief exposure to hypoxia recruits pluripotent stem cells to the peripheral circulation and actives
diverse transcriptional programs that are orchestrated by a selective number of key genes.
Background
Hypoxia is a pathophysiologic condition commonly seen
in lung diseases and in many other disorders such as tissue
ischemia and cancer [1]. In the developing embryo expo-
sure to global reduction in tissue oxygen is a critical factor
in recruitment and selective differentiation of embryonic
stem cells that orchestrate organogenesis [2]. The presence
of hypoxic microenvironments in adult tissues, as seen for
example in solid tumors or during ischemic injury, can
also lead to activation and recruitment of stem cells from
specific tissue niches, including the bone marrow (BM)
[3]. Under such local hypoxic circumstances, resident BM
stem cells have been shown to become mobilized and
facilitate the structural and functional repair of injured
organs [4-6]. The effects of global hypoxia on stem cell
activation and recruitment remain poorly understood
despite being a common feature of many pulmonary disor-
ders, and increasing evidence that BM-derived circulating
progenitor cells may play a causative role in acute lung
injury, pulmonary hypertension, pulmonary fibrosis and
COPD [7-10].
Recently, Ratajczak et al isolated a homogenous popula-
tion of rare, small stem cells from adult murine BM
mononuclear cells that expressed embryonic lineage mar-
kers, and were thus named very small embryonic-like stem
cells (VSELs) [11]. Pluripotency of these Sca-1
+ Lin
- CD45
-
stem cells was established by demonstrating their ability to
differentiate into cells representing all three germ layers
[12]. Bone marrow-resident VSELs can be mobilized to
the peripheral blood (PB) in response to specific chemoat-
tractant gradients, including stromal derived factor-1
(SDF-1), hepatocyte growth factor (HGF), and leukemia
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any medium, provided the original work is properly cited.inhibitory factor (LIF) [12,13]. Since SDF-1 is upregulated
in response to hypoxia [14], it seemed plausible that che-
mokine-dependent recruitment of VSELs can occur during
tissue injury characterized by hypoxia. Indeed, recent
reports have demonstrated that these pluripotent stem
cells are mobilized from BM to PB following organ
damage associated with significant hypoxic burden, includ-
ing ischemic stroke [15] and myocardial infarction [16].
Exposure to reduced oxygen tension causes widespread
perturbations in cellular transcription [17] that is con-
trolled by a number of critical regulators, most promi-
nently hypoxia inducible factors (HIFs) [18]. While gene
expression profiling of stem cells under various differen-
tiating conditions has been undertaken [19], the tran-
scriptional consequences of hypoxia in these cells is less
studied. Recently, Westfall et al reported on the effects of
4% vs. 20% oxygen on gene expression of cultured
human embryonic stem cells, and concluded that lower
oxygen tension (4%) in vitro more accurately captures
the true “physiologic” oxygen exposure in vivo by preser-
ving the pluripotent property of these cells [20]. Indeed, a
significant difficulty with all in vitro studies of hypoxic
exposure is establishing the physiologically relevant oxy-
gen tension during exposure [3,21] and retaining the
in vivo undifferentiated state of stem cells [22].
To overcome these limitations, we utilized an in vivo
murine model to systematically identify the transcriptional
response of BM-derived VSELs to hypoxia. We hypothe-
sized that exposing the animals to hypoxia will mobilize
VSELs from their BM to peripheral circulation in a stem-
cell specific chemokine gradient, and activate a spectrum
of transcriptional programs that captures the diverse, plur-
ipotent potential of these cells.
Methods
Animals
All animal experiments were performed according to
protocols approved by the Institutional Animal Care and
Use Committee (IACUC) of the University of Louisville.
Eight-week-old, adult, male, C57BL/J6 mice were pur-
chased from Jackson Laboratory (Bar Harbor, ME) and
housed in a specific pathogen free environment.
Hypoxic exposure
Mice were placed in identical commercially designed
chambers (Oxycycler model A44XO; Biospherix, Red-
field, NY, USA) that were operated under a 12:12-h light-
dark cycle (6:00 a.m to 6:00 p.m.). Gas was circulated
around each of the chambers, attached tubing, and other
units at 10 l/min to maintain low ambient CO2 levels. An
O2 analyzer measured the O2 concentration continuously
and deviations from the desired concentration were cor-
rected by addition of N2 or O2 through solenoid valves
such that the moment-to-moment desired oxygen
concentration of the chamber was programmed and
adjusted automatically. Ambient CO2 in the chamber was
monitored periodically and maintained at < 0.01% by
adjusting overall chamber basal ventilation. Humidity
was measured and maintained at 40-50% by circulating
the gas through a freezer and silica gel. Ambient tem-
perature was kept at 22-24°C. Hypoxic mice were
exposed to FiO2 o f8 % ,al e v e lt h a ti sa s s o c i a t e dw i t h
reproducible oxyhemoglobin saturations in the 75-80%
range. Control animals were exposed to circulating room
air (FiO2: 21%). Animals were exposed to hypoxia or nor-
moxia for a period of 24 h and sacrificed immediately
afterwards.
Isolation of VSELs from bone marrow and peripheral
blood
VSELs were isolated from murine bone marrow and
peripheral blood nucleated cells using multicolor fluor-
escence-activated cell sorting (FACS) as previously
described [4,12,23]. Briefly, the population of total
nucleated cells (TNCs) from murine PB and BM was
obtained after lysis of red blood cells using 1× BD
Pharm Lyse Buffer (BD Pharmingen, San Jose, CA,
USA). TNCs were subsequently stained for hematopoie-
tic lineage markers (Lineage - lin), for Sca-1 and CD45
antigens, for 30 minutes in medium containing 2% fetal
bovine serum. The following anti-mouse antibodies (BD
Pharmingen, San Jose, CA, USA) were used for staining:
anti-CD45R/B220 (phycoerythrin - PE; clone RA3-6B2),
anti-Gr-1 (PE; clone RB6-8C5), anti-T-cell receptor-ab
(PE; clone H57-597), anti-T-cell receptor-gδ (PE; clone
GL3), anti-CD11b (PE; clone M1/70), anti-Ter119 (PE;
clone TER-119), and anti-Ly-6A/E (Sca-1) (biotin; clone
E13-161.7, with streptavidin-conjugated to PE-Cy5) and
rat anti-CD45 (allophycocyanin-Cy7; clone 30-F11). All
mAbs were added at saturating concentrations. Cells
were then washed, re-suspended in RPMI 1640 medium
with 10% fetal bovine serum, and sorted by MoFlo cell
sorter (Dako, Carpinteria, CA, USA). The Sca-1+Lin-
CD45- cells (VSELs) and control Sca-1+Lin-CD45+ cells
(HSCs) were isolated according to the gating and sorting
strategy described before and outlined in Figure 1. For
each sample run, at least 10
6 events were acquired, with
VSELs accounting for 0.02-0.03% of the total cells (BM
or PB). Given the scarcity of VSELs in peripheral blood
and bone marrow, we performed six independent mea-
surements per exposure condition (hypoxia, normoxia),
each based on pooled samples from 10 mice, for a total
of 120 animals.
Measurement of plasma chemokines
Mouse blood was collected from the vena cava in vacu-
tainer tubes containing EDTA (Becton Dickinson,
Franklin Lakes, NJ, USA). The collected fresh blood was
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Figure 1 Isolation of VSELs from peripheral blood (Panel A) and bone marrow (Panel B) using FACS. Forward scatter (FSC) and side
scatter (SSC) distribution of beads with a range of diameters (1-15 μm, not shown) identified region 1 (R1) and was used to select populations
of peripheral blood (Panel A) or bone marrow mononuclear cells (Panel B) ranging in size between 2-10 μm (R1). The small, low complexity cells
in R1 were further separated using expression of Sca-1 and Lineage markers (R2: Sca-1
+ Lin
-), followed by sorting using CD45 marker expression
into two distinct populations (R3, R4): hematopoietic stem cells (HCS, Sca-1
+ Lin
- CD45
+), and very small embryonic-like stem cells (VSELs, Sca-1
+
Lin
- CD45).
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plasma was centrifuged for 5 minutes at 13,000 rpm to
remove remaining cells and platelets, and immediately
frozen at -80°C until further analysis. Levels of stem cell
chemokines stromal cell derived factor-1 (SDF-1), hepa-
tocyte growth factor (HGF), and leukemia inhibitory fac-
tor (LIF) were measured with ELISA kits (R&D Systems,
Minneapolis, MN) [23]. For the hypoxic exposure, 20
independent measurements and for the normoxic expo-
sure, 30 independent measurements were performed.
For each of these measurements, plasma was pooled
from 3-4 mice.
Statistical analysis
Chemokine levels and VSEL counts between hypoxia
and normoxia were performed using unpaired, two-
tailed Student’s t-test with P-values adjusted for unequal
variances when appropriate. Box and whisker represen-
tation of the data was used to depict the upper and
lower quartiles (box) and the maximum and minimum
values (whiskers).
Microarray experiments
VSELs were isolated from the bone marrows of 30 addi-
tional mice exposed to hypoxia and 30 mice exposed to
room air (pooled into six groups of n = 10). Total RNA
was isolated using PicoPure RNA Isolation Kit (Arcturus
Bioscience Inc., Mountain View, CA) and amplified using
Low-RNA Input Fluorescent Linear Amplification kit
(Agilent Technologies, Santa Clara, CA) with modifica-
tions. For each of the pooled groups (n = 10 mice per
group), labeled cRNA was hybridized to an Agilent murine
whole-genome 60-mer oligo microarray (Agilent Technol-
ogies, Santa Clara, CA) comprised of over 45,000 probes
as previously described [23]. Six independent hybridiza-
tions-3 pooled samples from mice exposed to hypoxia and
3 pooled samples from normoxic mice, were performed.
After image processing, background-subtracted intensities
were normalized using the quantile method [24].
Microarray data analysis
Two-dimensional hierarchal clustering using Pearson’s
correlation was performed on the entire normalized gene
expression data [25]. Differentially expressed genes in
VSELs exposed to hypoxia versus normoxia were identi-
fied using a Bayesian implementation of the parametric
t-test [26] and corrected for multiple comparisons with
the Q-value method [27]. A Q-value of < 0.05 was selected
for identifying significant differential gene expression.
Gene ontology analysis
Differentially expressed genes in VSELs (Q-value < 0.05)
underwent functional analysis with a web-based program,
Database for Annotation, Visualization and Integrated
Discovery (DAVID) and categorized using the Gene
Ontology database [28]. A permutation-based FDR analy-
sis was employed (FDR cutoff < 5%).
Network analysis
By including all differentially expressed genes during
hypoxia as initial seeds, we developed a gene product rela-
tional network based on published interaction databases
[29-31]. To maximize the accuracy of this “interactome”,
we limited the connection between any two nodes to
known direct relationships (e.g., protein-protein interac-
tion). The topological architecture of the network was
derived from its connectivity matrix. We tested the “scale-
free” property of the network by determining if it followed
a power law distribution [32]. We identified the key net-
work hubs by selecting differentially expressed nodes with
at least 10 connections.
Results
Effects of in vivo exposure to hypoxia on VSEL
populations and stem cell chemokines
We utilized a sequential gating strategy using FACS and
based on size, granularity and stem cell-specific antibody
staining to purify VSELs from PB and BM of mice exposed
to hypoxia and normoxic controls (Figure 1). In peripheral
blood, the white blood cell counts were 9,980 ± 467/ml in
normoxia and 10,503 ± 420/ml in hypoxia (p > 0.05); a
minimum of 100,000 cells were counted from merging the
samples from 10 mice to determine the frequency of
VSEL in peripheral blood for each independent sample
run. For bone marrow, cellularity was estimated from the
mixing of 10 mice to include approximately 1 million cells
for each independent sample run. Given the scarcity of
VSELs in peripheral blood and bone marrow, we per-
formed six independent measurements per exposure con-
dition (hypoxia, normoxia), each based on pooled samples
from 10 mice, for a total of 120 animals.
Exposure to hypoxia resulted in a significant increase in
the peripheral count of VSELs relative to their BM reserve
pool (Figure 2A-C). Furthermore, in vivo exposure to
hypoxia was associated with a significant elevation in
plasma levels of the stem cell chemoattractants SDF-1 and
L I F ,a n db o r d e r l i n ei n c r e a s ei nH G F( F i g u r e2 D - F ) ,p r o -
viding further evidence that hypoxia promotes a favorable
gradient for mobilization of VSELs from BM to PB.
Transcriptional profiling of VSELs during hypoxia
Global patterns in gene expression of BM-derived VSELs
exposed to hypoxia and normoxic controls were dissected
using hierarchical cluster analysis and displayed as a heat-
map (Figure 3). This analysis revealed that exposure to
hypoxia causes a perturbation in the entire VSEL tran-
scriptome that is distinct from the normoxic condition.
Within this genome-wide expression pattern, we identified
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of < 0.05 (Additional file 1, Table S1). The subsequent
pathway and network analyses were limited to this subset
of statistically significant differentially expressed genes.
Functional and network analyses of hypoxia-induced
transcriptional programs in VSELs
Functional enrichment analysis of differentially expressed
genes was performed using Gene Ontology analysis [28]
and graphically displayed based the hierarchical structure
of this annotation database (Figure 4). In vivo exposure
to hypoxia activated a diverse array of transcriptional
programs in pluripotent VSELs ranging from a number
of organ-specific developmental processes (e.g., lung, kid-
ney, skeletal, vascular, and nervous system development)
to pathways involved in defense and stress response,
cytokine and growth factor binding, and catalytic activity.
These results provide a blueprint mapping the profound
Figure 2 In response to in vivo exposure to hypoxia, VSELs are mobilized from bone marrow (BM) to peripheral blood (PB), and stem
cell chemoattractant gradients appear in plasma of mice. Panels A-C demonstrate that hypoxia causes a significant reduction in BM VSEL
number, a concurrent increase in PB VSEL count (although not reaching statistical significance) and an overall significant increase in the relative
ratio of these stem cells in PB vs. BM. Panels D-F show increased protein expression of three stem cell chemoattractants in response to hypoxia,
stromal cell derived factor-1 (SDF-1), leukemia inhibitory factor (LIF), and hepatocyte growth factor (HGF, does not reach statistical significance).
P-values were calculated using unpaired Student’s t-test. Box and whisker plots show the upper and lower quartiles (box) and the maximum and
minimum values (whiskers).
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VSELs in response to a brief in vivo hypoxic exposure.
Given the vast transcriptional effects of hypoxia on
VSELs, it is highly unlikely that a single gene will solely
orchestrate this response. To better elucidate the rela-
tionships among differentially expressed genes mapped
to the enriched functional groups and identify the key
controllers of hypoxia-induced transcriptional programs
in VSELs, we developed a gene product interaction net-
work, or interactome, based on previously published
direct interactions (Additional file 2, Figure S1). This
network consisted of 424 genes (nodes) and 604 connec-
tions (edges). Topologically, the interactome possessed
scale-free properties [32] because its degree distribution
(number of nodes with a given connection, Nk)a n d
nodal connectivity (k) were linked via a power law rela-
tionship-i.e., Nk ~k
-g (g = 1.64, R
2 = 0.98) (Additional
file 2, Figure S1). We and others have demonstrated
that the functional stability of complex biological net-
works is critically dependent on highly connected nodes
or “hubs” [33,34]. We identified the VSEL network hubs
by locating 18 differentially expressed nodes with at
least 10 interactions (Table 1). As shown in Figure 5A,
the connectivity pattern of these hubs captures a signifi-
cant proportion of the overall network structure (313
edges out of a total of 604). Furthermore, the key nodes
themselves are highly interconnected implying coordi-
nated, direct functional relationships between these
hubs (Figure 5B).
Discussion
The main finding of this work is that exposure to
hypoxia-a common characteristic of many lung disor-
ders, recruits pluripotent VSELs from BM to the periph-
eral blood and induces a distinct gene expression
signature in these stem cells. Using a computationally-
intensive approach, we mapped the functional and net-
work properties of activated transcriptional programs
a n di d e n t i f i e dh u b st h a tm a ys e r v ea sk e yr e g u l a t o r so f
the VSEL response to hypoxia.
To our knowledge, this is the first report on the global
transcriptional effects of hypoxia on stem cells using in
vivo exposure at physiologically relevant oxygen partial
pressures. Utilizing a similar strategy, we recently used a
murine model to investigate the consequences of cyclical
hypoxia during sleep on BM-derived VSELs [23]. The
intermittent hypoxic exposure was intended to model
obstructive sleep apnea and that project was therefore
more narrowly defined in its focus and clinical relevance.
Nevertheless, several of our current findings were also
observed in the intermittent hypoxia system, including
mobilization of VSELs from BM to PB, elevation of stem
cell chemoattractant chemokines, and enrichment of tran-
scriptional programs involved in development and organo-
genesis. Network analysis of the differentially expressed
genes in VSELs also revealed that some of the key hubs
were shared between the hypoxia models (intermittent,
sustained), including hypoxia inducible factor 2 alpha
(Hif2a), proliferator-activated receptor gamma (Pparg),
integrin beta 3 (Itgb3), and insulin growth factor binding
protein 5 (Igfbp5). This observation implies that global
exposure to reduced oxygen, whether continuous or inter-
mittent, activates a number of common pathways in pluri-
potent stem cells. However, there were also significant
differences in the transcriptional programs enriched in
VSELs under sustained vs. intermittent hypoxic exposure.
Firstly, a larger number of genes were differentially
expressed during continuous hypoxia suggesting a more
Figure 3 Two-dimensional hierarchical cluster analysis of bone
marrow-derived VSEL gene expression in mice exposed to
hypoxia or normoxia. The distinct gene expression patterns during
hypoxic exposure imply genome-wide transcriptional perturbation
in these pluripotent stem cells.
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tree structure. Functional categories reaching statistically significant enrichment (FDR cutoff < 0.05) and representing biological processes,
molecular functions and cellular components are depicted.
Table 1 Differentially expressed network hubs in VSELs exposed to in vivo hypoxia
Node Name Symbol Connectivity Q-value
FBJ osteosarcoma oncogene Fos 42 1.9 × 10
-2
Peroxisome proliferator activated receptor gamma Pparg 39 3.9 × 10
-2
Epidermal growth factor receptor Egfr 28 5.3 × 10
-4
Early growth response 1 Egr1 19 6.9 × 10
-3
Early growth response 2 Egr2 19 2.8 × 10
-2
Integrin beta 3 Itgb3 18 3.3 × 10
-3
TATA box binding protein Tbp 15 2.2 × 10
-2
Hypoxia-inducible factor 2 alpha Hif2a 15 1.7 × 10
-2
Collagen type I alpha 1 Col1a1 15 2.5 × 10
-2
Heat shock protein 8 Hspa8 14 4.1 × 10
-2
Insulin receptor substrate 1 Irs1 13 8.9 × 10
-5
Insulin-like growth factor binding protein 5 Igfbp5 12 5.7 × 10
-7
Heat shock protein 5 Hspa5 11 2.5 × 10
-2
Disrupted in schizophrenia 1 Disc1 11 8.1 × 10
-3
Homeobox A9 Hoxa9 11 1.8 × 10
-2
Von Willebrand factor homolog Vwf 11 9.1 × 10
-3
Peroxisome proliferative activated receptor gamma coactivator 1 alpha Ppargc1a 10 2.1 × 10
-4
Hypermethylated in cancer 1 Hic1 10 2.6 × 10
-2
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Figure 5 Differentially expressed hubs of the hypoxia-induced VSEL interactome. Panel (A) depicts the full network while highlighting
the18 hubs with ≥ 10 edges and their respective connections (see also Additional file 2, Figure S1). Note that these densely connected nodes
capture a significant proportion of the overall network connectivity (313 out of 604 connections). Red: upregulated in hypoxia, Green:
downregulated in hypoxia. Panel (B) is a wiring diagram limited to the interconnections among the network hubs, with each gene product
placed within its cellular compartment. This genetic circuit is postulated to encompass key controllers of stem cell responses during in vivo
hypoxia.
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trum of pathways was enriched in sustained compared to
intermittent hypoxia that extended beyond developmental
programs and included processes involved in defense and
stress response, wound healing, chemokine activity, cell
adhesion and structure (Figure 4). Thirdly, many of the
network hubs identified during exposure to continuous
hypoxia were not differentially expressed during cyclical
hypoxia (Figure 5, Table 1), including the most densely
connected node, Fos (FBJ osteosarcoma oncogene), and
several other key transcriptional regulators such as early
growth response 1 and 2 (Egr1, Egr2), and TATA box
binding protein (Tbp).
Fos and Egr1 are prototypic master regulators known
as immediate early-genes (IEG) that orchestrate wide-
spread activation of cellular gene expression in response
to specific perturbations, including hypoxia, ischemia,
atherosclerosis, angiogenesis, and neuronal survival
[35-37]. Egr2 has been shown to govern the develop-
ment and segmentation of the mouse hindbrain [38],
and mutations in this gene have been associated with
congenital hypomyelinating neuropathies in humans
[39]. Intriguingly, a recent study demonstrated that a
population of Egr2-expressing precursor cells develop
into the first embryonic respiratory rhythm-generating
neuronal circuit [40], and Egr2
-/- transgenic mice die
from breathing irregularities resulting in severe hypoxia
[41].
Two members of the heat shock protein 70 group,
Hspa8 and Hspa5, were also densely connected network
nodes whose expression increased significantly during
hypoxia. Products of these genes play crucial roles in
protecting cells from environmental stressors including
high temperature, oxidative stress, ischemia and hypoxia
[42]. More specifically, targeting Hspa8 and Hspa5 has
been demonstrated to protect cardiomyocytes [43] and
mesenchymal stem cells from hypoxia-induced apoptosis
[44], whereas delivering these heat shock proteins into
transplanted mesenchymal stem cells rescues heart func-
tion after myocardial infarction in rats [44].
Another differentially upregulated hub within the
interactome, Hif2a, is a member of the HIF family of
basic helix-loop-helix transcription factors that control
the global cellular response to oxygen deprivation. Hif2a
overexpression is seen many solid tumors characterized
with significant hypoxic burden including renal cell car-
cinoma, non small cell lung cancer and meduloblastoma,
and is associated with poor outcome in these cancers
[45]. Recent reports suggest that Hif2a is a critical acti-
vator of a subpopulation of cancer cells with stem cell-
like properties [46,47], and pharmacologic and genetic
targeting of this gene affects differentiation of progenitor
stem cells [48,49]. Interestingly, a single nucleotide poly-
morphism in Hif2a was recently demonstrated to be
highly associated with adaptability to high altitude
hypoxia in ethnic Tibetans [50].
The mobilization of VSELs from BM to peripheral cir-
culation in response to oxygen deprivation implies the
activation of organ-specific transcriptional programs
under regulatory controls. Our network analysis pro-
vided an overview of the transcriptional landscape of
these pluripotent stem cells during hypoxia. Since the
functional integrity of such scale-free biologic networks
is dependent on densely connected nodes [33], we pos-
tulate that these hubs comprise key regulators of
hypoxia-induced gene expression in VSELs. As depicted
in Figure 5, the hubs not only form the structural foun-
dation of the interactome, but are themselves highly
interconnected via direct interactions, implying a high
degree of functional coordination in orchestrating the
hypoxia-induced transcriptional response of stem cells.
To explore whether this hypoxia-induced transcrip-
tional signature is unique to VSELs or common among
leukocyte subpopulations, we compared our results to
expression profiles of mononuclear cells (MNCs) and
mesenchymal stem cells (MSCs) under hypoxia as
reported by Onishi et al [51]. While there are substan-
tial differences between the two studies in terms of
experimental protocols, hypoxic exposures, and microar-
ray platforms, less than 1% of the differentially expressed
genes in VSELs were significantly altered in MSCs or
MNCs, suggesting that many of the hypoxia-induced
genes in VSELs are exclusive to this subpopulation of
cells. However, from a functional standpoint, differen-
tially expressed genes in VSELs and MSCs were both
enriched in several developmental processes, whereas
MNCs were highly enriched in defense/immune
responses and inflammation. Therefore, VSELs appear
to possess transcriptional programs in common with
both MSCs and MNCs-a finding that is consistent with
their pluripotent properties.
Several limitations in the current study deserve men-
tion. We have only explored the effects of hypoxia on
gene expression and not assessed the post-transcrip-
tional modifications of gene products activated during
hypoxic exposure. The duration of hypoxia was short-
the long term consequences of chronic oxygen depriva-
tion on VSELs were not investigated in this study and
represent a future research goal. Although bone marrow
is the primary depot of VSELs, our results do not pre-
clude the possibility that some of these stem cells were
also mobilized from other tissue niches during exposure
to hypoxia. Nevertheless, our expression profiling
experiments were focused on BM-derived VSELs. We
have not identified the tissue source of hypoxia-induced
elevation in stem cells chemokines, but given the extre-
mely low number of circulating VSELs, we believe it is
unlikely that VSELs are the primary source. Although
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tractants, hypoxic injury to various tissues can lead to
the release of the chemokines into peripheral blood
[5,14,16]. Finally, we did not follow the fate of mobilized
VSELs to identify their target end organs, although
given the global effects of hypoxia and the diversity of
enriched developmental programs, we expect that these
stem cells will be recruited to multiple sites and
undergo tissue-specific differentiation.
Conclusions
Collectively, our results demonstrate that in vivo expo-
sure to hypoxia in mice elicits chemoattractant gradients
that promote the mobilization of pluripotent very small
embryonic-like stem cells from the bone marrow to per-
ipheral blood. A computationally-driven analysis of the
transcriptome of these cells highlighted the activation of
diverse transcriptional programs that appeared to be
coordinated by a select number of highly connected net-
work nodes. These hubs may represent critical targets
for modulating the functional consequences of hypoxic
burden on stem cells. Our approach provides a general
framework for the systematic study of stem cell biology
under clinically relevant pathophysiologic perturbations.
Additional material
Additional file 1: Tabular list of differentially expressed genes in
VSELs after hypoxic exposure. This file contains the list of differentially
expressed genes (based on a Q-value cutoff less than 0.05) in VSELs
exposed to hypoxia. The list includes the official gene symbols, Entrez
Gene IDs, Q-values, and Log2[expression in hypoxia/expression in
normoxia].
Additional file 2: Gene product interaction network of differentially
expressed genes in VSELs. This file contains two figures depicting a
gene product interaction network of differentially expressed genes in
VSELs after in vivo exposure to hypoxia. Panel (A) highlights up and
downregulated genes (red and green respectively). This network has 424
genes (nodes) and 604 connections (edges). Note that each connection
represents a known direct interaction between two gene products. Panel
(B) demonstrates that the topology of this network is scale-free because
it follows a power law distribution. Nk, degree distribution; k, nodal
connectivity.
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